Results show that HQJZD was mainly involved in signaling pathways of atherosclerosis, AGE-RAGE, T-cell receptors, TNF-α, IL-17, toll-like receptors, hepatitis C, pancreatic cancer, colorectal cancer, bladder cancer, toxoplasmosis, and others, in treating H. pylori gastritis. Here, IL17A is linked to pancreatic neoplasm.